Eyenuk, Inc.

At Eyenuk, we develop AI-based software medical devices for the detection and monitoring of sight threatening eye disorders, such as diabetic retinopathy, macular degeneration, and glaucoma, and systemic disorders such as cardiovascular disease and dementia. Our EyeArt AI system is the first and only FDA cleared AI technology for the autonomous detection of both more than mild and vision-threatening diabetic retinopathy. EyeArt is also approved for sale in the EU and Canada. Eyenuk in backed by over $40M investment, including a recent $22.5M series A funding. We are a small, growing team and are therefore looking for people who are generalists and like to learn. Experience with Python and cloud technologies is a plus. Experience with cybersecurity and/or HealthIT is also a plus.